All posts by imreal

Upper Limb Orthopedic Surgeon Dr. Alejandro Badia with Badia Hand to Shoulder Center Says Reversing Joint Calls for Experience and Skill, Offers Tips


Dr. Alejandro Badia

This procedure is complex and highly technical, requiring skill and experience. But switching the ball and socket can create a more stable joint with a fixed fulcrum in patients with severe shoulder damage, particularly damage involving the rotator cuff.

When it comes to shoulder repair, some surgeons are defying nature and doing it all backwards – and studies are showing that can be a good thing, says noted sports medicine and orthopedic specialist Alejandro Badia MD, an expert in treatment of musculoskeletal disorders of the upper limbs. He is referring to reverse shoulder replacement, also called reverse shoulder arthroplasty, in which artificial parts are used to change the natural anatomy of the shoulder’s ball-and-socket joint – the glenohumeral joint — by turning the ball at the top of the humerus (arm bone) into a socket and making the socket on the shoulder blade a ball.

“This procedure is complex and highly technical, requiring skill and experience. But switching the ball and socket can create a more stable joint with a fixed fulcrum in patients with severe shoulder damage, particularly damage involving the rotator cuff,” says Dr. Badia, founder and chief medical officer of the Florida-based Badia Hand to Shoulder Center and OrthoNOW®.

That’s because the rotator cuff, a group of muscles and tendons, is what normally powers the shoulder joint, allowing it to move and function properly. The rotator cuff keeps the ball of the arm bone centered on the shoulder-blade socket during joint rotation, including raising the arm. If the rotator cuff is too extensively torn, its tendons pulled from the bone, then a standard shoulder replacement, which maintains the shoulder’s natural ball-and-socket anatomy but requires an intact rotator cuff, will not prove effective in restoring regular shoulder function, Dr. Badia explains.

“Instead of relying on a damaged rotator cuff, a reverse shoulder replacement makes joint movement dependent on the deltoid muscle, a large, triangular-shaped muscle located on top of the shoulder and the uppermost part of the arm,” says Dr. Badia, who has years of experience in performing reverse shoulder replacements.

Most commonly, a reverse shoulder replacement is recommended for patients with significant pain due to extensive shoulder-joint osteoarthritis, with bone loss and missing or badly torn rotator cuff tendons, or for those whose quality of life is seriously impacted because a damaged rotator cuff prevents them from lifting their arm high enough for good functioning.

A complex upper arm bone fracture that involves damage to the shoulder-joint ball, chronic shoulder-joint dislocation, and a failed previous shoulder replacement also may necessitate a reverse replacement procedure, Dr. Badia says.

Although less frequently performed than hip or knee replacement surgery, shoulder replacement procedures in general have been increasing. Data from the Agency for Healthcare Research and Quality indicate more than 50,000 patients undergo shoulder replacement annually in the United States. Of these surgeries, as many as half are now reverse shoulder replacements, even though the procedure was only approved for use by the federal Food and Drug Administration about 15 years ago.

Because of the relative “newness” of reverse shoulder replacement, research to determine long-term outcomes of the procedure as it is performed in the U.S. remains scant. However, Dr. Badia indicates that studies in Europe, where the surgery has been done since the 1980s, underscore the procedure’s success in providing pain relief to as many as 90 percent of patients, restoring range of motion to the shoulder, and maintaining joint stability, with the prostheses – artificial parts used for reverse shoulder replacement – lasting up to 15 years.

In the U.S., a one-year follow-up of more than 200 patients who had undergone reverse shoulder replacement in 2017 at an average age of 70 showed “improvement in overall shoulder pain, function, and satisfaction,” according to the Cleveland Clinic’s Orthopaedic and Rheumatologic Institute.

Similar findings were reported in a study of “younger” and “more active” patients – those under age 60 – who had undergone reverse shoulder replacement due to massive, irreparable rotator cuffs and were followed up eight years or more after surgery. In that research, published in 2017 in The Journal of Bone & Joint Surgery, authors contend that the majority experienced “substantial and lasting improvement” in shoulder movement and strength and overall pain relief.

This same study found the rate of complications to be somewhat high — 39 percent. Complications can include loosening of prosthetic implants, instability of the reversed shoulder joint, persistent pain, nerve damage, bone fracture around the implant or overstressed deltoid muscle.

But Dr. Badia contends that ongoing advancements in prosthesis design, such as implants with shorter stems for the arm bone, and continuing improvements in surgical approaches are significantly reducing frequency of complications.

“That’s why it is so critical patients in need of shoulder repair and potential joint replacement consult highly experienced orthopedic surgeons who can properly diagnose their problem and offer them the best treatment options with minimal risk,” Dr. Badia concludes.

Alejandro Badia, MD, FACS, internationally renowned hand and upper-limb surgeon and founder of Badia Hand to Shoulder Center and OrthoNOW®, a walk-in orthopedic care clinic. He is a member of the American Society for Surgery of the Hand, American Association for Hand Surgery and the American Academy of Orthopedic Surgeons and an honorary member of many international professional hand societies. Dr. Badia specializes in treating all problems related to the hand and upper extremities, including trauma, sports injury, joint reconstruction, nerve injuries and arthroscopic surgeries. Go to OrthoNOWcare.com and drbadia.com.

Share article on social media or email:

Canon Claims BLI 2020 Copier MFP Line of the Year Award from Keypoint Intelligence


News Image

When it comes to reliability and usability, Canon’s copier MFP line is the standard bearer in the industry.

Keypoint Intelligence – Buyers Laboratory (BLI), the world’s leading independent evaluator of document imaging hardware, software, and services, today announced that Canon has won BLI’s coveted 2020 Copier MFP Line of the Year award. Given once a year, this award recognizes the vendor whose product line is deemed best overall based on its rigorous laboratory evaluations—and this marks the second time in the last three years that Canon has received this accolade.

“When it comes to reliability and usability, Canon’s copier MFP line is the standard bearer in the industry,” said George Mikolay, Keypoint Intelligence’s Associate Director of Copier MFP/Production Analysis. “We tacked on more than two million impressions on Canon’s copier engines this year and experienced just three misfeeds, which is simply outstanding and unmatched by any other vendor. Easy maintenance procedures and proactive device management help to further ensure that the products remain up and running. Plus, the models are so easy to use, with universal capabilities and features across the entire line. The well-designed touchscreen can be customized in many ways, all to suit individual users’ preferences. It’s also simple for users to pair their mobile devices with the MFP for printing and scanning. The devices are further complemented by an outstanding software line (Canon’s MEAP platform, uniFLOW and uniFLOW Online Express, and Universal Login Manager, to name several things) to boost security and, most importantly, control costs.”

“Canon is honored to be recognized by Keypoint Intelligence – Buyers Lab with the 2020 Copier MFP Line of the Year as it reflects our company’s holistic approach to meeting business needs and preparing our customers for the office of the future,” said Shinichi Yoshida, Executive Vice President and General Manager of Canon U.S.A., Inc. “We plan to continue delivering on our commitment to developing high-quality solutions designed to meet both market and customer needs in 2020 and beyond.”

ABOUT KEYPOINT INTELLIGENCE – BUYERS LAB

Keypoint Intelligence is a one-stop shop for the digital imaging industry. With our unparalleled tools and unmatched depth of knowledge, we cut through the noise of data to offer clients the unbiased insights and responsive tools they need in those mission-critical moments that define their products and empower their sales.

For over 50 years, Buyers Lab has been the global document imaging industry’s resource for unbiased and reliable information, test data, and competitive selling tools. What started out as a consumer-based publication about office equipment has become an all-encompassing industry resource. In a landscape that’s ever evolving, we change with it.

ABOUT BUYERS LAB LINE OF THE YEAR AWARDS

Line of the Year awards salute the companies that both provide a broad range of hardware or software and whose products consistently performed above average throughout testing. Much consideration is also made by Buyers Lab analysts and technicians in areas such as ease of use, features, and value, across an entire portfolio for that product area, with the end result being the most prestigious Buyers Lab awards offered.

SOCIAL MEDIA

Follow Keypoint Intelligence – Buyers Lab on Twitter

Connect with Keypoint Intelligence – Buyers Lab on LinkedIn

CONTACT

Deanna Flanick

+1 973-797-2145

deanna.flanick@keypointintelligence.com

Share article on social media or email:



cbdMD Celebrates Inaugural National CBD Month as Official Founder


cbdMD, Inc. a nationally recognized consumer cannabidiol (CBD) brand (NYSE American: YCBD), and the Registrar at National Day Calendar, have declared January as “National CBD Month.”

As the popularity of CBD continues to rise, millions of Americans are educating themselves on the prospective properties of CBD and how it can complement their everyday health and wellness routines. With a versatile array of CBD products to choose from, including tinctures, capsules, topicals, bath bombs, and a full pet product line up, cbdMD helps consumers experience which CBD application and regimen works best for their specific needs.

“National CBD Month is the perfect time to try CBD, especially for those who haven’t before,” said Ken Cohn, Chief Marketing Officer of cbdMD. “We believe in educating our consumers on not only what CBD is and how to introduce it into your daily lives, but also what to look for when researching trustworthy brands. We truly believe our product line at cbdMD is second to none, and we invite everyone to discover what truly superior CBD can do for them.”

About cbdMD

cbdMD, Inc. is a nationally recognized consumer cannabidiol (CBD) brand whose current products include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, and CBD pet products. cbdMD is also a proud partner of Bellator MMA, Life Time, Inc., and Supercross and has one of the largest rosters of professional sports athletes who are part of “Team cbdMD.” To learn more about cbdMD and our comprehensive line of over 100 SKUs of U.S. produced, THC-free CBD products, please visit: http://www.cbdmd.com or follow cbdMD on Instagram and Facebook, or visit one of the 4,000 retail outlets that carry cbdMD products.

Forward-Looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ”should,” ”may,” ”intends,” ”anticipates,” ”believes,” ”estimates,” ”projects,” ”forecasts,” ”expects,” ”plans,” and ”proposes.” These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, including, but not limited to, our ability to expand the sales of our CBD products through our partnerships, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-K for the fiscal year ended September 30, 2018, as filed with the Securities and Exchange Commission (the “SEC”) on December 12, 2018, our Quarterly Report on Form 10-Q for the period ended March 31, 2019, as filed with the SEC on May 15, 2019, our Quarterly Report on Form 10-Q for the period ended June 30, 2019, as filed with the SEC on August 14, 2019, and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.

Share article on social media or email:



Anomet Composite Clad Metal Wire is Ideal for use in Sensors, Switches, Connectors, Implantable Medical Devices, and Other Applications in Harsh Environments


Featuring 2% or more cladding thickness to produce wire that meets design requirements and cost criteria.

Featuring 2% or more cladding thickness to produce wire that meets design requirements and cost criteria.

Anomet Composite Clad Metal Wire combines up to three metals or alloys to achieve specific properties such as corrosion-resistance, biocompatibility, or operation at temperatures from cryogenic to 1200°C.

Anomet Products has introduced new custom engineered clad metal wire composites that can achieve specific properties for use in harsh environments inside or outside of the human body.

Anomet Composite Clad Metal Wire combines up to three metals or alloys to achieve specific properties such as corrosion-resistance, biocompatibility, or operation at temperatures from cryogenic to 1200°C. Featuring 2% or more cladding thickness to produce wire that meets design requirements and cost criteria, the clad wire is ideal for use in sensors, switches, connectors, implantable medical devices, and other applications in harsh environments.

Metallurgically bonded together to provide high reliability, flexibility, and optimum formability without breaking, flaking, or blistering, Anomet Composite Clad Metal Wire is available in sizes from 0.002” to 0.125” O.D. Incorporating a gold, silver, palladium or platinum exterior layer, the core and second layer can include copper, stainless steel, Kovar®, niobium, Nitinol®, nickel-iron, molybdenum, tantalum, and titanium.

Anomet Composite Clad Metal Wire is priced according to materials and configuration and is approximately one-tenth the cost of solid products.

For more information contact:

Anomet Products, Inc.

Daniel F. Lambert, Technical Marketing

830 Boston Turnpike

Shrewsbury, MA 01545

(857) 302-2523 FAX (508) 842-0847

e-mail: dlambert@anometproducts.com

http://www.anometproducts.com

Share article on social media or email:

Through an exciting and culture enhancing transaction Andesa Services, Inc is pleased to announce their 165 employees now own 100 percent of the company


Way back when we were talking about the values of the company, the idea that the company would remain in the hands of the employees and under control of the employees was a vision we had. – John Walker

Through an exciting and culture enhancing transaction Andesa Services, Inc is pleased to announce their 165 employees now own 100 percent of the company, through an employee stock ownership plan (ESOP) executed by the Shareholders earlier today. An ESOP is an employee benefit plan which provides company stock to employees as part of their retirement benefit. The ESOP is in addition to Andesa’s existing 401(k) retirement program.

A strong venture capital and M&A market exists in the U.S. today, particularly for technology-based companies. So, this type of transaction is unusual in the insurance technology sector. After 36 years in business, the shareholders had several alternatives to succession. However, they determined an ESOP was the best way to enhance the firm’s employee-focused culture, continue alignment with its life insurance client partners, position the company for future growth and live into the Andesa Forever vision.

John Walker, Andesa’s Founder and Board Member shared a video message with the new employee-owners upon completion of the ESOP transaction. “This is one of the most exciting days of my life and I hope you share my excitement. Way back when we were talking about the values of the company, the idea that the company would remain in the hands of the employees and under control of the employees was a vision we had. I am excited that we have such a great staff to turn this responsibility over to. I am excited for you and I hope you are excited for the opportunities it will provide you.”

“In today’s market, there are many different ways to address ownership succession,” noted Ron Scheese, Andesa’s President & CEO. “Most succession strategies were not the right fit for Andesa, its employees and the client relationships that we have worked so hard to build over the decades. We have strived to build a great culture and our employees have been the critical factor in that long-term success. This noteworthy moment in our history empowers us even more to preserve our vision and values by which we continue this great company journey. I am beyond excited to walk the next steps with my fellow-owners in pursuit of our Forever vision.”

ESOPs were developed in the US as a mechanism to facilitate the owners of privately held businesses to transfer ownership to their employees over time in a tax efficient manner. It was set up to create a market for the shares of a departing owner or a closely held company in a way that preserves the independence of the business and protects employment in the local economy.

About Andesa:

Andesa Services provides comprehensive, integrated policy administration, plan administration and support solutions for life insurance and annuity carriers and producers. Andesa began as a pioneer in the field of COLI/BOLI policy administration. Today more than 30 years later, Andesa’s integrated approach to insurance and plan administration results in efficiency gains, reduced hardware costs, mitigated compliance risk and improved market response. The Company offers a comprehensive suite of services for policy and plan administration in a secure, private cloud environment. Andesa partners with numerous insurance companies, including 6 of the top 13 life and annuity carriers, along with several top producers. The Company’s highly-experienced team of U.S.-based professionals provides insurers and producers large and small with administrative support for complex plan and product offerings.

Share article on social media or email:

The U.S. Toy Company Adds Two New Executives


U.S. Toy / Constructive Playthings, since 1953, a third-generation family-owned manufacturer and distributor of playthings that are both educational and fun, has announced two new appointments to its executive team.

Bill Bordegon, an accomplished sales and marketing executive and toy veteran, will help guide U.S. Toy Company’s sales and marketing efforts, including developing strategies to further expand the company’s distribution across broad and diversified specialty brick & mortar retailers and help strengthen its marketing initiatives and product development.

Bordegon was the national sales manager of Toysmith where he was credited with helping the company significantly grow its sales and distribution and increasing the company’s presence and market share. Also, as the director of sales & marketing for Orb, he helped the company expand its distribution and leadership position in the market and helped diversify its craft and STEM activities lines – resulting in significant annual increases in sales. Additionally, Bordegon has served on the board of directors for the American Specialty Toy Retailing Association (ASTRA) as chairman and secretary. Bordegon entered the toy business in 1994 and was the executive vice president for a division of Marvel.

Doug Bordegon has been added to the executive team as the vice president of sales & marketing for both the Constructive Playthings Division and U.S. Toy Commercial Division. Doug is an accomplished sales and marketing executive. He brings 11 years of senior sales and marketing success with leading companies including Whirlpool and Sprint. He is also co-founder/owner of Borda Productions, a leading company in the Midwest for music festivals and live entertainment.

“Doug and Bill are well-respected and talented executives and we are extremely fortunate to now have them on our management team,” said Seth Freiden, CEO/Owner, U.S. Toy Company. “Additionally, their wealth of experience in all facets of marketing including building brands, product development, licensing and integrated merchandising and promotional programs will help us continue to expand and grow our business throughout the world.”

“I am excited to be joining the U.S. Toy and Constructive Playthings team, a family-owned company that is known for its broad selection of quality products and its excellent customer service. We will be aggressively growing our business in the early childhood education markets and with specialty toy retailers,” said Doug Bordegon.

About U.S. Toy Company

U.S. Toy has been family owned and operated with pride since 1953. We are celebrating our 67th year of taking care of our customers and providing quality products – these are the family principles that are passed generation-to-generation. Our products are sold around the world to the early education market, specialty toy retailers, museums, zoos, aquariums, national parks, gift stores, craft, hobby, attractions, and theme parks. The company offers a broad selection of over 1,900 kid-favorite products in attractive packaging and displays for specialty retailers; and 3,700 products developed by teachers for teachers and the early childhood education centers.

Contact

U.S. Toy Company

Doug Bordegon

Vice President Sale & Marketing

(913) 461-6452

dbordegon@ustoy.com

ustoykidfun.com

constructiveplaythings.com

Share article on social media or email:

Guardians of opioid-dependent babies seek MDL class certification before Judge Polster


Attorneys representing America’s most innocent victims in the nation’s prescription opioid crisis took a significant step today within the Multi-District Litigation before Judge Daniel Polster in Cleveland, Ohio by seeking class certification of the guardians responsible for children injured by in-utero exposure to opioids and diagnosed with Neo-Natal Abstinence System or drug dependence.

States, cities, municipalities, hospitals and Native Americans have already gained such class certification status. Those classes do not include guardians of children who were born with Neo-Natal Abstinence Syndrome or drug dependent.

This would be the first-time children diagnosed with Neonatal Abstinence Syndrome, due to the opioid use of their birth mothers, would finally have redress of the lifelong physical and development disabilities and defects these children do and will experience, said Attorney Scott Bickford.

Mr. Bickford, who has argued on behalf of children with NAS for nearly two years before Judge Polster, said his team is being expanded by the legal expertise of Marc Dann, the former Attorney General of Ohio, and class-action experts Kelly and Tom Bilek.

“These children are the most vulnerable and blameless victims of the opioid crisis and will need lifelong medical monitoring and surveillance, as well as medical and social support services,” said Mr. Dann.

“This generation of children is not yet lost but will be without substantial intervention. For two years, their needs have been subordinated to the less urgent needs of government entities which do not have the legal ability to bring claims for these children, do not owe the duty of care to them and will never guarantee their on-going needs are met. Nevertheless, the child’s guardian will surely face and bear the fiduciary responsibility,” Dann added.

The legal filing, with supporting evidence from leading medical experts in the areas of NAS and the scientific relationship between in-utero opioid exposure and birth defects, puts forth studies and testimony to support these arguments, making these main points:


  • The nation is vastly undercounting the number of NAS babies, and data shows the number of babies with NAS babies born in the U.S.—now estimated at one every 15 minutes by the Centers for Disease Control– are far greater than the official government count because of flaws in how this information is gathered.
  • Babies are sent home from hospitals to guardians with little awareness of what the child and caregiver will face. While physical deformities may be evident when a baby is born, the growing medical science in the NAS area shows opioid exposure in the womb impacts brain size and development which results in long-term developmental effects such delays in walking, talking, hyperactivity, impulsive behaviors, aggression, learning disabilities and other problems which won’t demonstrate until the child ages.
  • Governments, schools and other institutions don’t understand the needs of these children because there is no registry of babies with NAS. Thus, families have no roadmap for the challenges ahead. Such a map can only be provided by establishing a registry and providing long-term medical monitoring and research. “This will allow for the program to reach out to the impacted families at the appropriate times,” wrote West Virginia Dr. Charles Werntz III, and also help identify the most hard-hit regions.

Certification of a nationwide class of guardians of NAS children must occur in 2020, the attorneys argue in today’s filing on behalf of families in 34 state class actions. This is underscored by the fact that nationwide, one of every five pregnant women on Medicaid has been prescribed opioids, the filing claims.

“In addition to medical monitoring claims to the guardian, plaintiffs seek to ensure that money needed to pay for testing and epidemiology is actually spent for the direct benefit of children born with NAS. More urgently, intervention and education of doctors and women of child-bearing age is required to immediately stop the possibility of more such births by educating them and the public that opioids cannot be used during pregnancy,” said Mr. Dann.

The link to the filing and supportive statements is here.

Share article on social media or email:

GNO Snoring and Sinus Offers New Laboratory Test for Chronic Sinusitis


“The Verigene System allows us to enhance the accuracy of our diagnoses and provide treatment tailored to each patient.  The entire diagnostic process is accomplished in one visit.”

GNO Snoring and Sinus, the New Orleans area experts in office based treatments for sleep apnea and sinusitis, has acquired a new laboratory test for their practice, improving their diagnostic accuracy and treatment for patients suffering from Chronic Sinusitis.  The VERIGENE® System by Luminex enables the clinicians at GNO Snoring and Sinus to rapidly identify pathogens responsible for some of the most complex and persistent cases of chronic sinusitis. 

“The Verigene System allows us to immediately determine whether or not our patients are suffering from viral or bacterial sinusitis,” said Dr. Akash Anand of GNO Snoring and Sinus.  “This is important because should a patient have a viral flare up of their chronic sinusitis, they do not require antibiotic treatment.  This allows us to reduce the number of antibiotics prescribed and prevent patients from developing resistance to key antibiotic medications, which they may need in the future.”

“All too often patients are prescribed antibiotics for sinusitis, when in most cases the culprit is a virus, not bacteria. The Verigene System allows us to enhance the accuracy of our diagnoses and provide treatment tailored to each patient.  The entire diagnostic process is accomplished in one visit.  Patients no longer need to schedule a separate visit to a hospital or outpatient laboratory for this test.” 

The GNO Snoring and Sinus laboratory is both certified with the Clinical Laboratory Improvement Amendments (CLIA) – a federally-overseen program who’s tasked with regulating and ensuring quality laboratory testing – as well as COLA accredited – a program approved by The Centers for Medicare and Medicaid Services (CMS) and specializing in clinical laboratory education, consultation and accreditation.

For more information about GNO Snoring and Sinus, call 504.309.8615 or visit gnosnoring.com.

Share article on social media or email:

Sunrise Systems Electronics Co., Inc. and SES America, Inc. Merge to Form Sunrise SESA Technologies, Inc.


The combination of Sunrise and SESA completely aligns with our vision of delivering intelligent display systems that improve communication shared on roadways and throughout the transit ecosystem.

Sunrise Systems Electronics Co., Inc. (Sunrise) and SES America, Inc. (SESA) have merged to form Sunrise SESA Technologies, Inc. The combined business will add to the innovation and support both companies can collectively bring to their customers by helping solve the increasingly complex challenges faced in the transit and transportation industries.

“The combination of Sunrise and SESA completely aligns with our vision of delivering intelligent display systems that improve communication shared on roadways and throughout the transit ecosystem. We understand the current and future needs of the market and the importance of providing real-time intelligence to improve the experience of getting from place to place,” said Zack Farahmand, President and CEO of Sunrise and Managing Director at Axiom Capital.

“We are looking forward to joining forces with the Sunrise team. As a partner on several projects, we experienced first-hand the positive results of combining the strengths of our teams’ engineering expertise and manufacturing capabilities to deliver the highest value solutions for our customers,” said Phil Perut, President of SES America.

Both Sunrise and SESA have long histories of serving the transit and transportation industries and the merger will bring together skilled teams and domain expertise to deepen the companies’ commitment to delivering high quality and innovative solutions to the current and future needs of the market.

About Sunrise Systems Electronics Co., Inc.

Sunrise Systems Electronics Co., Inc. is a leading manufacturer of LED display technology and custom signage for the bus, rail and commercial markets, including financial services and higher education. Founded in 1976, Sunrise has been a lifelong producer of first-in-the-industry technological advances and uniquely tailored information systems.

About SES America, Inc.

Founded in 1986 in Rhode Island, SES America, Inc. is a high-quality multi-sign solution manufacturer for the ITS industry focused on providing Dynamic Message Signs and retrofit packages to clients across the United States and Canada. SESA is proud to say that their signs are manufactured in the U.S.

Share article on social media or email:

Learn How Technology is Bringing Convenience to Healthcare


News Image

During 1Q/2020, Advancements with Ted Danson will explore breakthroughs in healthcare technology and solutions. Check your local listings for more information.

For several years, the hospital industry has been seeing signs of a pending shortage of nurses, physicians, and leadership. Throughout the country, hospitals, surgical centers, and assisted living facilities continue having trouble finding qualified candidates to fill healthcare staffing gaps. In addition, unprecedented turnover has only exacerbated shortages.

This episode of Advancements will explore FleetNurse, a company that provides hospitals, medical groups, and health systems with access to quality credentialed healthcare providers on emergency short-term notice – helping to reduce understaffing and affiliated costs, while improving patient care.

Viewers will learn about FleetNurse’s software and will see how it screens and qualifies providers who want to work per diem shifts. The show will also educate about how FleetNurse uses technology and its network of nurses and providers to connect them with facilities to ensure that patient care is not diminished due to lack of staff, while providing jobs within local communities, therefore, helping the local economy.

About FleetNurse:

FleetNurse started because of a need. A need for qualified, credentialed healthcare providers at healthcare facilities. With FleetNurse, nurses can work the hours and shifts they want without having to compromise their work-life harmony. FleetNurse credentials the nurses and provides facilities with access to these quality nurses. Nurses can work when they want to work. Whether they want to work 8 hours a week or 120 hours a month, it is their choice.

For more information, visit: http://www.fleetnurse.com.

About Advancements and DMG Productions:

The Advancements series is an information-based educational show targeting recent advances across a number of industries and economies. Featuring state-of-the-art solutions and important issues facing today’s consumers and business professionals, Advancements focuses on cutting-edge developments, and brings this information to the public with the vision to enlighten about how technology and innovation continue to transform our world.

 Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming on which both viewers and networks depend.

 For more info, please visit: AdvancementsTV.com or call Brett Ferrigan at 866-496-4065.

Share article on social media or email: